TARO

Taro Pharmaceutical Industries Ltd.
TARO

Overview Fund Activity
Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

109 hedge funds and large institutions have $500M invested in Taro Pharmaceutical Industries Ltd. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 45 reducing their positions, and 13 closing their positions.

Holders
109
Holders Change
–
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
14
Increased
27
Reduced
45
Closed
13
Calls
$336K
Puts
$255K
Net Calls
+$81K
Net Calls Change
+$108K

Top Buyers

1
Arrowstreet Capital
1
Arrowstreet Capital
Massachusetts
$24.4M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$27.3M
3
Robeco Institutional Asset Management
3
Robeco Institutional Asset Management
Netherlands
$3.84M
4
Morgan Stanley
4
Morgan Stanley
New York
$8.32M
5
Northern Trust
5
Northern Trust
Illinois
$9.4M

Top Sellers

1
MICM
1
Matthews International Capital Management
California
$16.7M
2
Schroder Investment Management Group
2
Schroder Investment Management Group
United Kingdom
$2.81M
3
Millennium Management
3
Millennium Management
New York
$6.41M
4
LP
4
LMR Partners
United Kingdom
$0
5
BIP
5
Brandes Investment Partners
California
$7.64M
Name Holding Trade Value Shares
Change 		Shares
Change %
JAM
26
Jupiter Asset Management
United Kingdom
$4.71M – – –
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$4.27M +$302K +2,611 +8%
Robeco Institutional Asset Management
28
Robeco Institutional Asset Management
Netherlands
$3.84M +$3.84M +33,170 New
AIIMS
29
Analyst IMS Investment Management Services
Israel
$3.62M – – –
Canada Pension Plan Investment Board
30
Canada Pension Plan Investment Board
Ontario, Canada
$3.58M -$1.2M -10,377 -25%
SCP
31
Seizert Capital Partners
Michigan
$3.41M – – –
Goldman Sachs
32
Goldman Sachs
New York
$3.22M -$608K -5,256 -16%
MWNA
33
Marshall Wace North America
New York
$2.85M +$2.6M +22,460 +1,037%
Schroder Investment Management Group
34
Schroder Investment Management Group
United Kingdom
$2.81M -$26.9M -233,504 -91%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$2.76M -$96.3K -833 -3%
Boston Partners
36
Boston Partners
Massachusetts
$2.72M +$2.72M +23,541 New
OAM
37
Oxford Asset Management
United Kingdom
$2.51M +$562K +4,878 +29%
JPMorgan Chase & Co
38
JPMorgan Chase & Co
New York
$2.48M -$2.47M -21,312 -50%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$2.33M +$982K +8,492 +73%
AG
40
Aperio Group
California
$2.23M -$782K -6,757 -26%
EF
41
Empirical Finance
Pennsylvania
$1.59M +$493K +4,263 +45%
Connor, Clark & Lunn Investment Management (CC&L)
42
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.48M +$1.48M +12,750 New
SFM
43
Systematic Financial Management
New Jersey
$1.37M -$256K -2,215 -16%
Charles Schwab
44
Charles Schwab
California
$1.16M +$238K +2,054 +26%
HCM
45
Hudson Capital Management
New Jersey
$1.07M +$143K +1,235 +15%
SEI Investments
46
SEI Investments
Pennsylvania
$1.03M -$603K -5,206 -37%
ACA
47
Anchor Capital Advisors
Massachusetts
$944K -$157K -1,359 -14%
Barclays
48
Barclays
United Kingdom
$891K -$509K -4,401 -36%
Creative Planning
49
Creative Planning
Kansas
$825K – – –
AIM
50
Assured Investment Management
New York
$815K -$607K -5,248 -43%
1
2
3 4 5